Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective

Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized...

Full description

Bibliographic Details
Main Authors: Costanza Varesio, Ludovica Pasca, Stefano Parravicini, Martina Paola Zanaboni, Elena Ballante, Silvia Masnada, Cinzia Ferraris, Simona Bertoli, Anna Tagliabue, Pierangelo Veggiotti, Valentina De Giorgis
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/11/7/1650
id doaj-6d518439dcc849f7bd8907bb2ab5f9a5
record_format Article
spelling doaj-6d518439dcc849f7bd8907bb2ab5f9a52020-11-25T01:20:41ZengMDPI AGNutrients2072-66432019-07-01117165010.3390/nu11071650nu11071650Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population PerspectiveCostanza Varesio0Ludovica Pasca1Stefano Parravicini2Martina Paola Zanaboni3Elena Ballante4Silvia Masnada5Cinzia Ferraris6Simona Bertoli7Anna Tagliabue8Pierangelo Veggiotti9Valentina De Giorgis10Department of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyBioData Science Center, IRCCS Mondino Foundation, 27100 Pavia, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyHuman Nutrition and Eating Disorder Research Center, Department of Public Health, Experimental and Forensic Medicine University of Pavia, 27100 Pavia, ItalyInternational Center for the Assessment of Nutritional Status (ICANS), Department of Food Environmental and Nutritional Sciences (DeFENS), University of Milan, Via Sandro Botticelli 21, 20133 Milan, ItalyHuman Nutrition and Eating Disorder Research Center, Department of Public Health, Experimental and Forensic Medicine University of Pavia, 27100 Pavia, ItalyPediatric Neurology Unit, Vittore Buzzi Hospital, Via Lodovico Castelvetro 32, 20154 Milan, ItalyDepartment of Child Neurology and Psychiatry, IRCCS Mondino Foundation, Via Mondino 2, 27100 Pavia, ItalyBackground: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3−22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10−100) for physical functioning, 74.23 (range 30−100) for emotional functioning, 62.64 (range 10−100) for social functioning, and 56 (range 15−92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception.https://www.mdpi.com/2072-6643/11/7/1650ketogenic diet treatmentGLUT1 deficiency syndromehealth related quality of lifePedsQol 4.0
collection DOAJ
language English
format Article
sources DOAJ
author Costanza Varesio
Ludovica Pasca
Stefano Parravicini
Martina Paola Zanaboni
Elena Ballante
Silvia Masnada
Cinzia Ferraris
Simona Bertoli
Anna Tagliabue
Pierangelo Veggiotti
Valentina De Giorgis
spellingShingle Costanza Varesio
Ludovica Pasca
Stefano Parravicini
Martina Paola Zanaboni
Elena Ballante
Silvia Masnada
Cinzia Ferraris
Simona Bertoli
Anna Tagliabue
Pierangelo Veggiotti
Valentina De Giorgis
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
Nutrients
ketogenic diet treatment
GLUT1 deficiency syndrome
health related quality of life
PedsQol 4.0
author_facet Costanza Varesio
Ludovica Pasca
Stefano Parravicini
Martina Paola Zanaboni
Elena Ballante
Silvia Masnada
Cinzia Ferraris
Simona Bertoli
Anna Tagliabue
Pierangelo Veggiotti
Valentina De Giorgis
author_sort Costanza Varesio
title Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
title_short Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
title_full Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
title_fullStr Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
title_full_unstemmed Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
title_sort quality of life in chronic ketogenic diet treatment: the glut1ds population perspective
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2019-07-01
description Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3−22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10−100) for physical functioning, 74.23 (range 30−100) for emotional functioning, 62.64 (range 10−100) for social functioning, and 56 (range 15−92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception.
topic ketogenic diet treatment
GLUT1 deficiency syndrome
health related quality of life
PedsQol 4.0
url https://www.mdpi.com/2072-6643/11/7/1650
work_keys_str_mv AT costanzavaresio qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT ludovicapasca qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT stefanoparravicini qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT martinapaolazanaboni qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT elenaballante qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT silviamasnada qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT cinziaferraris qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT simonabertoli qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT annatagliabue qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT pierangeloveggiotti qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
AT valentinadegiorgis qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective
_version_ 1725132706805710848